Globalisation on pause? How scaleups can navigate today's uncertainty9:30 am - 10:30 am
BGF exits investment in Renal Services
BGF has successfully exited its investment in Renal Services, an independent provider of dialysis services, after it was acquired by DaVita UK Limited, a DaVita International Group Company.
Headquartered in London, Renal Services operates 21 dialysis units across the UK and treats over 1,300 permanent and transient patients with kidney disease. Set up in 2007, Renal Services is the third-largest dialysis provider in the UK.
Alongside its equity investment, BGF contributed additional support to the company through the introduction of James Buckley as Non-Executive Chairman. James has an extensive background in the healthcare sector, formerly as CEO of Tunstall Group, Chairman of Ark Home Healthcare and Mangar International, and Non-Executive Director of Prism Medical.
Founded and led by serial international healthcare entrepreneur Stefano Ciampolini, Renal Services has opened 16 new clinics in the UK since BGF invested as a minority equity partner. The business has also posted strong organic growth during this time.
Stefano Ciampolini, founder and former CEO of Renal Services commented: “When we met BGF, we had ambitious plans for growth and a strategy to increase our provision of sites to meet patient demand. BGF was instrumental in helping us to execute our plan and make our company the fastest growing dialysis provider in the UK with a CAGR of approximately 30% since 2014.
“Our inspired patient care and clinical quality outcomes have progressed steadily over the years, making Renal Services a leading provider of dialysis care for people with kidney disease. I am also very proud of how the management team and senior staff have developed and grown professionally over the years. Personally, this has been an exciting and rewarding journey and I am confident that all stakeholders will benefit from the leadership and global experience provided by DaVita going forward. The team will now be led by Kathy Lloyd who was the first member to join me at the start of the venture in 2007.”
Matthew Simcox, investor at BGF, said: “Renal Services is a robust, ambitious business that has grown significantly over the last six years. With our investment, we have helped take Renal to the next level, through the development of new sites, services and technologies. The business has seen steady growth during this time and has delivered a strong return for BGF. We wish the team all the best on the next stage of their journey.”
Business funding news
OSL receives £3.5 million follow-on investment as impressive growth continues
BGF has invested a further £3.5 million into leading counter-drone technologies business Operational Solutions Limited (OSL), taking its total investment…
ViaNautis raises £20 million Series A financing to drive the next generation of genetic nanomedicines
ViaNautis Bio, a ground-breaking nanomedicine company at the forefront of genetic therapies, has completed its Series A funding round, raising…